optalert, Author at Optalert

OPTALERT LAUNCHES DROWSINESS DETECTION VALIDATION SERVICE

PRESS RELEASE WORLD LEADING DROWSINESS & ALERTNESS DETECTION COMPANY, OPTALERT LAUNCHES DROWSINESS DETECTION VALIDATION SERVICE Tuesday, 27 April 2021 Optalert, the world’s leader in drowsiness and alertness detection, today launched its Drowsiness Detection Validation Service to enable drowsiness monitoring systems providers assess their solutions against scientifically validated measures based on sensitive physiological markers. “We have had a number of providers assess their solutions for drowsiness detection in the automotive industry. The introduction of this capability into Driver Monitoring Systems (DMS) as specified by the Euro NCAP program is an excellent [...]

By optalert|2021-04-27T08:03:11+10:00April 27th, 2021|Automotive|

Introducing the eagle LIGHT

In a year of turbulence and unknowns, Optalert are pleased to bring you some exciting news. Optalert’s early warning drowsiness detection system has now been developed specifically to suit light vehicles such as: 4WD’s, DualCabs, small commercial vehicles. The eagle LIGHT is a small form factor device which pairs with Optalert wireless glasses. Robust and ruggedized in design, its compact size system, easy installation, and startup/shutdown with vehicle ignition, make it ideal for smaller commercial vehicles. Building on the 20 years of R&D that created the scientifically validated Johns [...]

By optalert|2020-08-10T15:16:53+10:00August 10th, 2020|Goods & Passenger Transport, Mining|

Interview with Dylan Young – Race Car Driver, Safety Advocate and Optalert Ambassador

Motor racing is both a physically challenging and mentally demanding sport. Its associated with a high degree of safety risk for drivers, whereby the slightest error could lead to fatal consequences. Drowsiness and inattentiveness are amongst the most dangerous risks faced by any driver, yet alone a race car driver who’s preparing to be at his peak performance on the track. In an interview with Dylan Young, racing car driver, safety advocate and Optalert ambassador, he shares his insights into the dangers of drowsy driving. What first drew you [...]

By optalert|2020-07-22T09:48:59+10:00July 22nd, 2020|Automotive, Neurology|

Safely navigating through a crisis

2020 will go down as one of the most difficult for companies and leaders around the world. The corona virus has taken lives, isolated families, closed airports and put a fear into many like never before. Whilst most of us have had the privilege of a stable life occupied with routine, the future is now filled with uncertainty and disruption. As our new normal evolves, some organizations will be strong enough to survive, but a great number will fold. Leaders have never been more challenged to guide their teams through [...]

By optalert|2020-05-26T15:31:20+10:00May 25th, 2020|Automotive, Goods & Passenger Transport, Mining, Neurology, Pharmaceutical|

What’s the difference between fatigue and drowsiness?

Sleep is essential for your brain function as well as your body. Medical research shows sleep loss has detrimental effects on our health from weight gain to a weakened immune system. It can impact memory, increase risk of accidents, diabetes, the likelihood of cancers and has profound effects on the cardiovascular system1. Even a one-off sleep deprived situation, can cause drowsiness, cognitive impairment and increases the potential for a dangerous situation to occur. Day light savings increases sleep deprivation, drowsiness and health risks The man drive a car with [...]

By optalert|2020-03-27T11:31:41+11:00March 27th, 2020|Automotive|

What is the Optalert JDS™ and why is it leading the drowsiness monitoring field?

Optalert’s sophisticated software algorithm, leads the drowsiness monitoring field, by providing the next level layer within driver monitoring systems (DMS). Optalert’s scientifically validated Johns Drowsiness Scale (JDSTM) enables an objective, real time, quantifiable measure of drowsiness. Applicable across ethnicity, gender and age, the JDS™ empowers the driver with the ability to avoid dangerous microsleeps. Providing a continuous numerical score of the driver’s impairment, the system not only cautions the driver, but it also informs the vehicle, with early prediction of drowsiness. Drowsy drivers display certain driving behaviour as their ability [...]

By optalert|2020-02-26T22:07:27+11:00February 26th, 2020|Pharmaceutical|

Optalert named in Top 5 Global Driver Monitoring Startups Automotive

Top 5 Out Of 200 Driver Monitoring Startups In Automotive StartUs INSIGHTS article: We analyzed 200 Driver Monitoring startups in the automotive industry. Sighthound, Optalert, CardioID, Edge3, and Sober Steering are our 5 picks to watch out for. To learn more about the global distribution of these 5 and 195 more startups, check out our Heat Map! Related topics:AUTOMOTIVE INDUSTRYDRIVER MONITORINGHEAT MAP Our Innovation Analysts recently looked into emerging technologies and up-and-coming startups in the automotive industry. As there is a large number of startups working on a wide variety [...]

By optalert|2020-01-30T12:15:11+11:00January 30th, 2020|Automotive|

Their image analysis reveals who you are – giants on the customer list

Di - Swedish financial site - Published:January 18, 2020 After just over ten years of revenue darkness, Visage Technologies began selling its technology to analyze facial images. "It was our breakthrough," says Jörgen Ahlberg. Photo: Henrik Lenngren It started out as a less lucrative hobby business for some researchers who needed to "code off". Today, Visage Technologies has sales of SEK 42 million, and the company's face recognition software is used in everything from makeup test apps to bathroom mirrors. Jörgen Ahlberg flips through a thumbs-up book from the early 2000s when he [...]

By optalert|2020-01-21T16:20:06+11:00January 21st, 2020|Automotive|

Optalert Drowsiness & Attentiveness Monitoring

[fusion_builder_container hundred_percent="no" equal_height_columns="no" menu_anchor="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id="" background_color="" background_image="" background_position="center center" background_repeat="no-repeat" fade="no" background_parallax="none" parallax_speed="0.3" video_mp4="" video_webm="" video_ogv="" video_url="" video_aspect_ratio="16:9" video_loop="yes" video_mute="yes" overlay_color="" video_preview_image="" border_size="" border_color="" border_style="solid" padding_top="" padding_bottom="" padding_left="" padding_right=""][fusion_builder_row][fusion_builder_column type="1_1" layout="1_1" background_position="left top" background_color="" border_size="" border_color="" border_style="solid" border_position="all" spacing="yes" background_image="" background_repeat="no-repeat" padding_top="" padding_right="" padding_bottom="" padding_left="" margin_top="0px" margin_bottom="0px" class="" id="" animation_type="" animation_speed="0.3" animation_direction="left" hide_on_mobile="small-visibility,medium-visibility,large-visibility" center_content="no" last="no" min_height="" hover_type="none" link=""][fusion_text] Optalert is pleased to announce the availability of its latest driver monitoring software solution. Providing the most advanced measure of drowsiness & attentiveness in the automotive market, this gives Tier [...]

By optalert|2020-03-03T14:26:27+11:00December 19th, 2019|Automotive|

Could blinks be the answer to Alzheimer’s disease?

September is World Alzheimer’s month, the international campaign which raises awareness and challenges the stigma that surrounds dementia. Around the world 50 million people have dementia, and each year there are nearly 10 million new cases. The total number of people with dementia is projected to reach 82 million by 2030! With over 100 forms of dementia, the most well-known form is Alzheimer’s disease (AD), which accounts for 50-60% of all cases. Although a widespread condition, diagnosis and treatment of AD today is inadequate. Often multiple tests including patient history, [...]

By optalert|2019-09-03T16:23:57+10:00September 3rd, 2019|Neurology, Pharmaceutical|

About optalert